ATOLL-bio

Weingarten, Germany Founded: 2004 • Age: 22 yrs Acquired By Repligen
Chromatography columns for pharmaceuticals are developed and distributed.

About ATOLL-bio

ATOLL-bio is a Healthcare company based in Weingarten (Germany) founded in 2004, and was acquired by Repligen in April 2016. Chromatography columns for pharmaceuticals are developed and distributed. ATOLL-bio offers products and services including Gaming Platform. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Chromatography.

Company details

ATOLL-bio was established in 2004 in Weingarten, Germany, within the biopharmaceutical sector. Chromatography columns are developed, manufactured, and distributed by the company to support downstream processing needs. The MediaScout platform is offered as a technology solution for process development in pharmaceutical applications. Operations focus on providing tools for purification and separation in drug manufacturing workflows.

  • Headquarters Weingarten, Germany
  • Stage Acquired
  • Sectors
    Healthcare
  • Website atoll-bio.com
  • Acquired by Repligen (Apr 2016)
Key Metrics

Products & Services of ATOLL-bio

ATOLL-bio offers a comprehensive portfolio of products and services, including Gaming Platform.

Gaming Platform
Online Gaming Service

Secure interface for accessing diverse online games for user entertainment.

Investors in ATOLL-bio

ATOLL-bio has secured backing from 1 investor. Prominent investors backing the company include Repligen.

All
InvestorDescriptionFounded YearDomainLocation
Products and services for biologic drug manufacturing are supplied.
1981repligen.comWaltham, United States
Premium access

Investor details for ATOLL-bio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of ATOLL-bio

2 dated milestones of ATOLL-bio across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded ATOLL-bio is founded.
  2. Exit Acquired by Repligen.

Web traffic of ATOLL-bio

The website of ATOLL-bio (atoll-bio.com) receives about 3.4K visits a month.

  • Monthly visits
    3.4K

    ▼ 84.3% vs previous month

Similar websites

Websites whose visitors overlap most with ATOLL-bio. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
google.de
google.de
100%
#175–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about ATOLL-bio

ATOLL-bio was founded in 2004.

ATOLL-bio is headquartered in Weingarten, Germany. It is registered at Weingarten, Baden-wurttemberg, Germany.

ATOLL-bio was established in 2004 in Weingarten, Germany, within the biopharmaceutical sector. Chromatography columns are developed, manufactured, and distributed by the company to support downstream processing needs. The MediaScout platform is offered as a technology solution for process development in pharmaceutical applications. Operations focus on providing tools for purification and separation in drug manufacturing workflows.

ATOLL-bio offers Gaming Platform.

ATOLL-bio has 1 investor. Key investors include Repligen.

Yes. ATOLL-bio was acquired by Repligen in April 2016.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available